Risk Factors and TAVR - Cardiovascular Update

Predictors of permanent pacemaker requirement in aortic stenosis patients undergoing self-expanding valve transcatheter aortic valve replacement using the cusp overlap technique

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

IntroductionSince TAVR was approved for lower-risk aortic stenosis (AS) patients, managing post-implantation conduction disturbances has become crucial, especially with self-expanding heart valves (SEV).

Pacemaker

Pacemaker Aortic Stenosis Aortic valve

Case Report: A case of transcatheter aortic valve replacement in a patient with a small aortic annulus using the Acurate Neo2

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2025

Small aortic annulus poses a major challenge in aortic valve replacement due to the increased risk of prosthesispatient mismatch (PPM) and increased surgical risk. In recent years, transcatheter aortic valve replacement (TAVR) has emerged as a popular alternative to the traditional surgical aortic valve replacement.

Aortic valve

Aortic valve Aortic TAVR Myocardial Infarction

State-of-the-Art Review Provides Strategies to Address Post-TAVR CDs and PPI

American College of Cardiology

DECEMBER 10, 2024

A State-of-the-Art review published in JACC: Cardiovascular Interventions covers the epidemiology, clinical implications, risk factors and preventive strategies for new-onset conduction disturbances (CDs) and the need for permanent pacemaker implantation (PPI) after TAVR, which the authors note are a limitation of this therapy.

TAVR

TAVR Pacemaker Cardiovascular Interventions Risk Factors

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Alternative access in transcatheter aortic valve replacement—an updated focused review

Frontiers in Cardiovascular Medicine

AUGUST 7, 2024

However, with the compelling evidence on the safety and efficacy of transcatheter aortic valve replacement (TAVR), it has become the gold standard treatment option for many patients with symptomatic severe AS. Therefore, alternative TAVR approaches have gained increasing utility in cases where transfemoral access is unfavorable.

Aortic valve

Aortic valve Aortic TAVR Peripheral Arterial Disease

Post?TAVR conduction abnormalities leading to permanent pacemaker implantation: Risk factors, prevention, and management

Journal of Cardiovascular Electrophysiology

JANUARY 22, 2024

Abstract Transcatheter aortic valve replacement (TAVR) often leads to conduction abnormalities, necessitating pacemaker implantation. This review of 38 meta-analyses identified preexisting right bundle branch block (RBBB), LAHB, and new-onset left bundle branch block as key risk factors, with a higher PPM risk in male and older patients.

TAVR

TAVR Risk Factors Pacemaker Aortic valve

Osteosarcopenia — A New Risk Factor for Mortality After TAVR

NEJM Journal Watch - Cardiology

MAY 23, 2024

The combination of low muscle mass and bone density was associated with a threefold increase in 1-year mortality risk.

Risk Factors

Risk Factors TAVR

Impact of cardiac rehabilitation on pre- and post-operative transcatheter aortic valve replacement prognoses

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Transcatheter aortic valve replacement (TAVR) is a relatively new treatment method for aortic stenosis (AS) and has been demonstrated to be suitable for patients with varying risk levels.

Aortic valve

Aortic valve Cardiac Rehabilitation Aortic TAVR

Predictors, clinical impact, and management strategies for conduction abnormalities after transcatheter aortic valve replacement: an updated review

Frontiers in Cardiovascular Medicine

APRIL 7, 2024

Transcatheter aortic valve replacement (TAVR) has increasingly become a safe, feasible, and widely accepted alternative surgical treatment for patients with severe symptomatic aortic stenosis.

Aortic valve

Aortic valve Aortic TAVR Risk Factors

Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

European Journal of Heart Failure

FEBRUARY 26, 2025

This clinical consensus statement provides a comprehensive overview of low BP in HFrEF, including its definition, risk factors, and effects of HF therapies on BP. Low blood pressure with major or mild symptoms. **SBP SBP <80mmHg or symptomatic low BP or asymptomatic low BP.

Blood Pressure

Blood Pressure Heart Failure Aortic valve TAVR

Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial

Circulation

OCTOBER 25, 2023

The objectives of this study were to compare the hemodynamic and clinical outcomes between transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in patients with a SAA.Methods:Prospective multicenter international randomized trial performed in 15 university hospitals.

Aortic valve

Aortic valve Aortic TAVR Stenosis

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

FEBRUARY 29, 2024

ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24 24 and how those may impact clinical practice and patient care in this deep dive clinical trial session.

Aortic valve

Aortic valve Myocardial Infarction Aortic Blood Pressure

Incidence, outcomes and predictors of bleeding after transfemoral TAVR

Cardiology Update

JANUARY 31, 2024

Transcatheter aortic valve replacement (TAVR) has emerged as the preferred treatment for older patients suffering from severe aortic valve stenosis, surpassing the annual patient count of those opting for surgical aortic valve replacement. Notably, TAVR demonstrates lower rates of periprocedural major bleeding compared to traditional surgery.

TAVR

TAVR Aortic valve Outcomes Aortic

Hypercapnia during transcatheter aortic valve replacement under monitored anaesthesia care: a retrospective cohort study

Open Heart

AUGUST 30, 2024

Background Acute intraoperative hypercapnia and respiratory acidosis, which can occur during monitored anaesthesia care (MAC), pose significant cardiopulmonary risks for patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR).

Aortic valve

Aortic valve Aortic TAVR Stenosis

Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndrome

Frontiers in Cardiovascular Medicine

APRIL 24, 2024

With this longer lifespan, calcific aortic stenosis (AS) was identified as an emerging critical risk factor for cardiac death in older patients. Modified transcatheter aortic valve replacement (TAVR) and left ventricular Apico-Aortic Conduit (AAC) placement were deemed high risk but viable options. years by 4.3

Stenosis

Stenosis Aortic Peripheral Arterial Disease TAVR

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Part 2: Empirical Studies in Cardiac Surgery; Risk Model Recommendations The Annals of Thoracic Surgery January 2022 David Shahian Social Risk Factors in Society of Thoracic Surgeons Risk Models.

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Ram Kumar The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2021 Update on Outcomes and Research The Annals of Thoracic Surgery December 2021 Jennifer Nelson Capturing Adult Congenital Heart Disease: Framework for Development of an Adult Congenital Heart Disease Mortality Risk Model The Annals of Thoracic Surgery November 2021 Laura (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Predictors of permanent pacemaker requirement in aortic stenosis patients undergoing self-expanding valve transcatheter aortic valve replacement using the cusp overlap technique

Case Report: A case of transcatheter aortic valve replacement in a patient with a small aortic annulus using the Acurate Neo2

State-of-the-Art Review Provides Strategies to Address Post-TAVR CDs and PPI

Webinars

Alternative access in transcatheter aortic valve replacement—an updated focused review

Post?TAVR conduction abnormalities leading to permanent pacemaker implantation: Risk factors, prevention, and management

Osteosarcopenia — A New Risk Factor for Mortality After TAVR

Impact of cardiac rehabilitation on pre- and post-operative transcatheter aortic valve replacement prognoses

Predictors, clinical impact, and management strategies for conduction abnormalities after transcatheter aortic valve replacement: an updated review

Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

Incidence, outcomes and predictors of bleeding after transfemoral TAVR

Hypercapnia during transcatheter aortic valve replacement under monitored anaesthesia care: a retrospective cohort study

Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndrome

Published Research

Published Research

Stay Connected